Understanding Bladder Response to BCG Treatment
Author Information
Author(s): Saban Marcia R, Simpson Cindy, Davis Carole, Wallis Gemma, Knowlton Nicholas, Frank Mark Barton, Centola Michael, Gallucci Randle M, Saban Ricardo
Primary Institution: Oklahoma University Health Sciences Center
Hypothesis
Does intravesical Bacillus Calmette-Guerin (BCG) induce a unique set of cytokines in bladder inflammation compared to other pro-inflammatory stimuli?
Conclusion
BCG induces a unique type of persisting bladder inflammation that is different from other classical pro-inflammatory stimuli.
Supporting Evidence
- BCG treatment led to a significant increase in IL-17 family genes.
- BCG induced a higher PMN influx compared to LPS and TNF-α.
- Unique granuloma formation was observed only in response to BCG.
- Urinary cytokine levels were significantly altered following BCG treatment.
- BCG was shown to induce a comprehensive cytokine response.
- IL-1β, IL-2, IL-3, IL-4, IL-6, IL-10, IL-17, GM-CSF, KC, and Rantes were identified as key discriminators of BCG response.
Takeaway
BCG treatment for bladder issues causes a special kind of inflammation that lasts longer than other treatments, and it makes certain proteins in the body go up.
Methodology
C57BL/6 female mice received four weekly instillations of BCG, LPS, or TNF-α, followed by morphometric analyses and multiplex analysis of urinary cytokines.
Potential Biases
Potential bias in cytokine measurement due to the small sample size at each time point.
Limitations
The study primarily used a mouse model, which may not fully replicate human responses.
Participant Demographics
C57BL/6 female mice, aged 10-12 weeks.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website